“…Its activity has been documented in plasma, erythrocytes, leukocytes, dermal fibroblasts, and various organs, such as kidney, brain, heart, thymus, uterus, liver, small intestine, stomach, spleen, lung, and pancreas (Zanaboni et al, 1994;Liu et al, 2007). Prolidase activity has been investigated in various disorders, such as chronic liver disease (Myara et al, 1984), osteoporosis (Erbagci et al, 2002), osteoarthritis (Altindag et al, 2007), uremia (Gejyo et al, 1983), and hypertension (Demirbag et al, 2007), and in the presence and severity of coronary artery disease (Yildiz et al, 2008).…”